Akèy › Adenom selil ilot
Etid klinik pou Adenom selil ilot ap rekrite nan Etazini
12 etid pou Adenom selil ilot ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Los Angeles, CA5 etid
- St. Louis, MO5 etid
- Rochester, MN5 etid
- Chicago, IL4 etid
- Washington, DC4 etid
- Salt Lake City, UT4 etid
- Phoenix, AZ4 etid
- Lexington, KY4 etid
- Columbus, OH4 etid
- Portland, OR4 etid
- Baltimore, MD3 etid
- Boston, MA3 etid
- Nashville, TN3 etid
- Cedar Rapids, IA3 etid
- New York City, NY3 etid
- Jacksonville, FL3 etid
- Tampa, FL3 etid
- Seattle, WA3 etid
- Philadelphia, PA3 etid
- Omaha, NE3 etid
- Irvine, CA3 etid
Pa eta
- Arizona4 etid
- Florid5 etid
- Illinois5 etid
- Iowa4 etid
- Kalifòni7 etid
- Kentucky4 etid
- Maryland4 etid
- Massachusetts3 etid
- Michigan3 etid
- Minnesota5 etid
- Missouri5 etid
- Nebraska3 etid
- New York4 etid
- Ohio5 etid
- Oregon4 etid
- Pennsylvania4 etid
- Tennessee4 etid
- Texas3 etid
- Utah4 etid
- Virginia3 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04924075Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07165132Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT05687123Nutrition Intervention for Pancreatic Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT07554560Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT05477576Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Mar 17, 2026 · NCT04119024Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 9, 2026 · NCT00830557Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 26, 2026 · NCT05746182Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT06663072Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT05040360Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.